Targeting the β <sub>2</sub> ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolismHatice Satilmis, Kim De Veirman|The Journal of Pathology|2022Cited by 16